VerityRankVerityRank
Back to Rankings
Sakata Seed Corporation
Brand VerifiedJapan

Sakata Seed Corporation

SAKATA

Sakata Seed Corporation is a Japanese seed house founded in Yokohama in 1913, listed on the Tokyo Stock Exchange Prime market under code 1377 and selling its genetics worldwide under the single brand SAKATA. It is not a Fortune Global 500 member: FY2026 revenue of JPY 104.2 billion, roughly US$680 million, is below the threshold used to draw up the 2025 list. Its 81 score rests instead on a share of one vegetable crop that no other company on this table comes close to holding.

The company began as a Yokohama seed merchant and spent the twentieth century becoming a breeder that develops, multiplies and finishes its own varieties rather than trading other people's. Broccoli became the franchise. Sakata's share of the world broccoli seed market is put at more than 60 percent in one of the two research documents behind this profile and 65 percent in the other; either number makes it the reference manufacturer for the crop. Ornamentals are the second leg, led by the SunPatiens impatiens series and lisianthus varieties sold to professional flower growers. FY2026 sales reached JPY 104.2 billion and net profit rose 25 percent to JPY 12.1 billion, a year in which profit outgrew turnover.

Category purity is high and deliberate. The portfolio is seed, not agrochemicals: proprietary hybrids in broccoli, cabbage, lettuce, watermelon and tomato on the vegetable side, and in impatiens, lisianthus and other cut-flower and bedding crops on the ornamental side. There is no crop protection or fertiliser line sitting alongside, so margin depends on genetics, on seed quality and on the production discipline behind it.

Physical assets follow the seed. Breeding farms, tissue-culture laboratories and seed processing plants operate across 22 countries, with high-specification cleaning plants and trial grounds in Japan, in California, in France, in Brazil and in Suzhou in China. Gravity separation, sizing and coating lines of that kind are what allow a breeder to commit to germination percentages and lot-to-lot uniformity instead of buying cleaned seed from a third party. Tissue culture adds a second production route for crops where in-vitro propagation beats field multiplication.

Sales are business-to-business. Customers are professional growers, distributors and, in flowers, plug and young-plant producers in more than 130 countries, and gross margin has been held above 45 percent on proprietary varieties rather than on volume. Two recent decisions point the same way: the Antalya Research Farm opened in Turkey in 2025, and in 2026 the Spanish subsidiary moved its headquarters to Almeria, both aimed at the protected-culture vegetable growers of the Mediterranean basin.

The first risk is currency translation. A Japanese company earning in dollars and euros against a yen cost base absorbs the full effect of yen volatility, and rising labour costs at overseas farms, processing sites and research stations squeeze the margin on cross-border operations in the short run. The second is delivery on PASSION2035, the ten-year plan adopted on 13 July 2026 with a target of JPY 200 billion in annual sales by FY2036, close to double the current figure, which depends on growth rates the vegetable and flower franchises have not recently produced.

Read More ▼
JapanEst. 1913~2,800JPY 104.2 billion - about…Breeding farms, tissue-culture…Tokyo Stock Exchange PrimeScore 81
Last Updated: October 2026·By VerityRank Research Team·Methodology

Business Nature

Sakata Seed is a listed Japanese breeder-producer rather than a merchant house: it owns the genetics it sells and keeps the multiplication and conditioning that turn a breeding line into a commercial lot. Breeding runs on company farms and trial grounds in Japan and abroad, tissue-culture laboratories multiply material for crops where in-vitro propagation beats field production, and processing plants handle cleaning, sizing and coating. The output is proprietary vegetable and flower seed sold under one brand to professional growers. Ownership is publicly traded: the shares are listed on the Tokyo Stock Exchange Prime market under code 1377, with no controlling family, co-operative or state shareholder and no parent group whose accounts it sits inside. Upstream, Sakata holds its own parent lines and breeding populations, the asset that makes the broccoli franchise defensible; downstream, seed is multiplied under supervision and harvested into company-owned conditioning plants. Subsidiaries in 22 countries reach 130-plus markets. What falls outside its own operations is narrow: field multiplication is contracted to growers rather than farmed wholly on company land, retail garden channels are not operated, and no crop protection or fertiliser line is attached.

Core Business Areas

Vegetable seed – proprietary hybrids sold to professional growers
• broccoli and other brassicas
• watermelon, melon and tomato
• lettuce, cabbage and leafy crops
Flower seed and young plants – ornamental genetics for commercial flower production
• SunPatiens impatiens series
• lisianthus varieties
• plug and young-plant supply
Seed production and conditioning – company-controlled multiplication and finishing
• breeding farms and trial grounds
• tissue-culture laboratories
• cleaning, sizing and coating plants
Research and regional development – breeding aimed at protected-culture and warm-climate markets
• Antalya Research Farm in Turkey
• Almeria-based Spanish operations
• Suzhou, California, France and Brazil sites

Industry Rankings

Corporate Report

Sakata Seed takes eighth position on this manufacturer table with a score of 81. The turnover is modest next to the companies above it, but the broccoli seed franchise is not: a global share above 60 percent built on hybrid genetics that rivals have not displaced. The rating credits that concentration of market power, and discounts it for a narrow product base and the currency exposure that comes with earning abroad from a Japanese cost base.

Industry Position

Founded in Yokohama in 1913 and traded on the Tokyo Stock Exchange Prime market as code 1377, Sakata reported FY2026 sales of JPY 104.2 billion, about US$680 million, and net profit of JPY 12.1 billion, up 25 percent on the prior year. Profit expanding faster than revenue is the signature of a seed business with pricing power in a narrow range of crops rather than of a volume distributor moving someone else's goods.

Subsidiaries in 22 countries and sales in more than 130 give the company a wide geographic footprint over a deliberately narrow product set. Against the direct peer group on this table - KWS, Rijk Zwaan, Enza Zaden and DLF - Sakata is mid-sized, which is why it ranks below them. What lifts it above a generic regional breeder is broccoli, where it is the manufacturer most professional growers buy from.

Competitive Advantages

Broccoli genetics are the moat. A world market share above 60 percent in a single vegetable crop is rare in an industry where most breeders hold single-digit positions across many species, and it survives because Sakata controls both the parent lines and the multiplication of the hybrid seed. Gross margin has stayed above 45 percent, a level that supports continued breeding investment out of cash flow rather than out of debt.

The flower business supplies a second, less correlated franchise. SunPatiens impatiens and lisianthus are sold to professional ornamental growers, and tissue-culture laboratories in Japan and abroad multiply material for crops that cannot be scaled through field seed production. Cleaning and processing plants in Japan, California, France, Brazil and Suzhou complete the chain in-house, which is what protects lot uniformity and germination guarantees.

Strategic Expansion

PASSION2035, adopted on 13 July 2026, sets a FY2036 sales target of JPY 200 billion, close to double the current figure. Because the company sells only seed, that target cannot be met by acquiring a chemical portfolio; it has to come from more vegetable share, more ornamental volume and a higher seed price per unit, which places the whole plan on the breeding pipeline.

Recent investment has leaned Mediterranean. The Antalya Research Farm in Turkey opened in 2025, and in 2026 the Spanish subsidiary relocated its headquarters to Almeria to sit closer to the greenhouse growers of southern Spain. Both moves target protected-culture vegetable producers and shorten the distance between breeding trials and the customers who plant the results.

Risks & Outlook

Currency is the immediate risk. Revenue is earned largely in US dollars and euros while a large share of research, breeding and processing cost is booked in yen, so sharp moves in the exchange rate unsettle reported margins between periods. Rising labour costs at overseas breeding farms, tissue-culture units and conditioning plants add a second squeeze that cannot be offset quickly by raising seed prices.

The longer risk is the growth gap inside PASSION2035. A JPY 200 billion target implies roughly a decade of expansion at a rate neither the vegetable nor the flower franchise has shown, and any shortfall invites pressure on the dividend and on research spending held above 45 percent gross margin. The broccoli position is durable; the plan around it is not yet proven. VerityRank Score of 81/100.

VerityRank Score

81/ 100

Based on market presence, financial scale, operational capacity, and brand strength.

Quick Facts

Headquarters

Yokohama, Kanagawa, Japan

Founded

1913

Employees

~2,800

Revenue

JPY 104.2 billion (FY2026) - about US$680 million

Factories

Breeding farms, tissue-culture labs and seed processing plants in 22 countries

Listing

Tokyo Stock Exchange Prime (1377)

Categories

Agricultural Products BrandsAgricultural Products SuppliersAgricultural ProductsPlant Propagation Materials Industry​Seeds IndustryFresh Vegetables IndustryPlant Propagation Materials BrandsPlant Propagation Materials Manufacturers

Data Sources & Methodology

This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.

VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.

Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.

Key references: Official Website , Sakata IR filings · PASSION2035 plan · Sakata FY2026 results · Sakata Seed valuation · Sakata IR home · Sakata share data